Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Axon guidance | R-HSA-422475 | map04360 | Trolox C | 221071 | drug-path |
| Epithelial cell signaling in Helicobacter pylori infection | 0 | map05120 | Trolox C | 221071 | drug-path |
| Fc epsilon RI signaling pathway | R-HSA-2454202 | map04664 | Trolox C | 221071 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | Trolox C | 221071 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | Trolox C | 221071 | drug-path |
| Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | clorsulon | 6307 | drug-path |
| ErbB signaling pathway | R-HSA-168638 | map04012 | clorsulon | 6307 | drug-path |
| Type II diabetes mellitus | R-HSA-2127377 | map04930 | clorsulon | 6307 | drug-path |
| GnRH signaling pathway | R-HSA-168638 | map04912 | clorsulon | 6307 | drug-path |
| Renal cell carcinoma | R-HSA-9794523 | map05211 | etamivan | 9363 | drug-path |
| Bladder cancer | R-HSA-9700206 | map05219 | etamivan | 9363 | drug-path |
| mTOR signaling pathway | R-HSA-165662 | map04150 | etamivan | 9363 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | etamivan | 9363 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | etamivan | 9363 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | etamivan | 9363 | drug-path |
| Antigen processing and presentation | R-HSA-1236975 | map04612 | etamivan | 9363 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | etamivan | 9363 | drug-path |
| Asthma | R-HSA-444620 | map05310 | etamivan | 9363 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | etamivan | 9363 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | etamivan | 9363 | drug-path |